JPRN-jRCT2080222295未知2 期
KD-357 Phase II/III Study
适应症
试验速览
- 阶段
- 2 期
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 <= 19age old（—）
- 性别
- All
入选标准
- •(1) Subjects who are healthy Japanese under 20 at the time of obtaining informed consent
- •(2) Legally acceptable representatives who are able to give written informed consent.
排除标准
- 未提供
研究者
相似试验
未知
3 期
KD-357 Phase III Studypreexposure prophylaxis against rabiesJPRN-jRCT2080222145The Chemo-Sero-Therapeutic Research Institute200
未知
2 期
KD-370 Phase II study.The prevention of pertussis, diphtheria, tetanus, poliomyelitis, and infection caused by Haemophilus influenzae type b.JPRN-jRCT2080222866The Chemo-Sero-Therapeutic Research Institute
未知
2 期
K012 phase II clinical studyColorectal cancerJPRN-jRCT2080220752ippon Kayaku Co., Ltd.
已完成
1 期
K-755 Phase 1 studyhealthy malesJPRN-jRCT2080224071Kowa Co., Ltd.78
未知
3 期
TK-641 Phase 3 StudyJPRN-jRCT2080221351TEIKOKU SEIYAKU CO., LTD.